Newly created niche CRO which is the world leader in testing vaccines & antivirals through human challenge studies. Open Orphan is actively involved in the fight against COVID-19
On the rise…
Does anyone know why?
They signed a £6.8 million contract for trials, guessing that is the initiative as it’s a step closer to being profitable.
A company i will have a read into i guess
They are certainly in demand at the moment.
Great interview with ceo, from a couple of weeks ago
Has anybody received the dividend due on 9th June?
Mo Khan, Hivivo CEO talking about new 50 bed facility, to be ready by q2 of 2024